Thu, Aug 15, 2024 2:00 PM – 3:00 PM EDT
Presenter: Carl Marci, MD, Chief Clinical Officer and Chief Psychiatrist and Managing Director of Mental Health and Neuroscience, OM1
Treatment-resistant depression (TRD) presents a formidable challenge for life sciences researchers, with its complex definition varying across clinical care, reimbursement, and regulatory contexts. This disconnect creates a pressing need for effective methodologies to gain insights into this elusive patient population.
Join OM1 for an insightful webinar where we explore the cutting-edge applications of AI and real-world data (RWD) to better understand TRD. Our experts will share the latest innovative research in mental health and depression, providing you with practical examples of how leading life sciences companies leverage RWD for their mental health programs.
- Innovative AI Applications: Understand how AI and RWD can identify undiagnosed patients with TRD, offering new pathways for research and treatment.
- Expert Perspectives: Hear from thought leaders about the latest thinking and advancements in the field.
- Real-World Applications: See concrete examples of how leading life sciences companies are using RWD to enhance their mental health programs.
Who Should Attend?
This webinar is tailored for life sciences teams who are passionate about advancing their understanding of complex conditions using the most innovative AI and machine learning techniques.
**Please be advised this webinar is intended for pharmaceutical and medical device companies. Due to the proprietary nature of the content, all registration approval is at the discretion of OM1. Vendors and consultants will not be permitted to attend at this time.